Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
BMC Med Genet ; 21(1): 163, 2020 08 18.
Artículo en Inglés | MEDLINE | ID: mdl-32811452

RESUMEN

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. Current studies have shown that PNPLA3 (Patatin-like phospholipase domain containing 3) rs738409 G/C gene polymorphism is associated with adult nonalcoholic fatty liver disease [1, 2].But there is no consensus on the relationship between PNPLA3 rs738409 G/C gene polymorphism and children NAFLD due to differences in population samples. To this end, a meta-analysis of published research is conducted to comprehensively assess the relationship between PNPLA3 gene polymorphism and NAFLD in children. METHODS: We searched MEDLINE, PubMed, EMBASE, and CENTRAL databases from inception to May 2019. Case-control studies assessing the relationship between PNPLA3 rs738409 G/C gene polymorphism with non-alcoholic fatty liver disease in children were selected according to inclusion and exclusion criteria. Random effects model was used to quantify the association between the PNPLA3 rs738409 G/C gene polymorphism and the susceptibility of children's NAFLD. Fixed effects model was used to quantify the relationship between the PNPLA3 rs738409 G/C gene polymorphism and the severity of NAFLD in children. The Stata 12.0 software was employed for data analysis. RESULTS: A total of nine case-control studies were included in this meta-analysis containing data of 1173 children with NAFLD and 1792 healthy controls. Five studies compared NAFLD children and non-NAFLD healthy populations. Statistical analysis showed that PNPLA3 gene polymorphism was significantly associated with children's NAFLD in the allele contrast, dominant, recessive and over dominant models (G vs C,OR = 3.343, 95% CI = 1.524-7.334; GG + GC vs CC,OR = 3.157, 95% CI = 1.446-6.892;GG vs GC + CC,OR = 5.692, 95% CI = 1.941-16.689; GG + CC vs GC,OR = 2.756, 95% CI = 1.729-4.392). Four case-control studies compared Children with nonalcoholic fatty liver (NAFL) and children with nonalcoholic steatohepatitis (NASH). The results showed that the PNPLA3 gene polymorphism was also significantly associated with the severity of NAFLD in children in recessive gene model (GG vs GC + CC,OR = 14.43, 95% CI = 5.985-34.997); The Egger's test revealed no significant publication bias. CONCLUSIONS: Meta-analysis showed that PNPLA3 gene polymorphism was significantly associated with susceptibility and severity of NAFLD in children.


Asunto(s)
Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Lipasa/genética , Proteínas de la Membrana/genética , Enfermedad del Hígado Graso no Alcohólico/genética , Polimorfismo de Nucleótido Simple/genética , Niño , Femenino , Humanos , Masculino , Oportunidad Relativa , Sesgo de Publicación
2.
BMC Cancer ; 19(1): 1128, 2019 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-31752753

RESUMEN

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth-most common malignancy worldwide. Multiple previous studies have assessed the relationship between TM6SF2 gene polymorphism and the risk of developing HCC, with discrepant conclusions reached. To assess the association of TM6SF2 rs58542926 T/C gene polymorphism with liver cancer, we performed the current meta-analysis. METHODS: This study queried the MEDLINE, PubMed, EMBASE, and CENTRAL databases from inception to April 2019. Case-control studies assessing the relationship between TM6SF2 rs5854292 locus polymorphism and liver cancer were selected according to inclusion and exclusion criteria. The Stata 12.0 software was employed for data analysis. RESULTS: A total of 5 articles, encompassing 6873 patients, met inclusion criteria and were included in the meta-analysis. Statistical analysis showed that the TM6SF2 gene polymorphism was significantly associated with liver cancer in the allele contrast, dominant, recessive and over dominant models (T vs C, OR = 1.621, 95%CI 1.379-1.905; CT + TT vs CC. OR = 1.541, 95%CI 1.351-1.758; TT vs CT + CC, OR = 2.897, 95%CI 1.690-4.966; CC + TT vs TC, OR = 0.693, 95%CI 0.576-0.834). The Egger's test revealed no significant publication bias. CONCLUSION: The present findings suggest a significant association of TM6SF2 gene polymorphism with HCC risk in the entire population studied.


Asunto(s)
Carcinoma Hepatocelular/genética , Neoplasias Hepáticas/genética , Proteínas de la Membrana/genética , Polimorfismo de Nucleótido Simple , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Humanos
3.
J Nanosci Nanotechnol ; 14(7): 4940-8, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24757965

RESUMEN

Highly fluorescent CdTe quantum dots (QDs) with emission in red to near-infrared (NIR) wavelength were successfully prepared by using 3-mercaptobutyric acid (3MBA) as capping agent. The maximum of quantum yield (QY) could reach up to 82% for QDs with emission peak at 686 nm and FWHM of 66 nm at optimal conditions. The QY of these QDs could maintain above 65% in the 650-750 nm region and QDs with emission over 800 nm were still strong fluorescent (28-41%). These optical properties of CdTe quantum dots are among the best results prepared by the state-of-the-art methods, suggesting their promising applications in bio-imaging. The success of 3MBA as excellent capping agent in this method was attributed to the balanced chain length and methyl side chain in comparison to a series of linear and branched mercapto acids, namely thioglycolic acid, thiolactic acid, 3-mercaptopropionic acid, 4-mercaptobutyric acid, 5-mercaptovaleric acid, 4-mercaptovaleric acid and 3-mercapto-2-methylbutyric acid.


Asunto(s)
Butiratos/química , Compuestos de Cadmio/química , Puntos Cuánticos , Espectrometría de Fluorescencia/métodos , Telurio/química , Agua/química , Cristalización/métodos , Rayos Infrarrojos , Ensayo de Materiales , Tamaño de la Partícula , Solubilidad
4.
J Nanosci Nanotechnol ; 6(12): 3947-9, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17256359

RESUMEN

A synthetic pathway is introduced to construct fluorescent composite macromolecules with supramolecular assemblies as structural units. The supramolecular assembly that contains polymerizable groups is used as a starting "monomer." The supramolecular assembly is composed of nanoparticle core of II - IV group semiconductor and organic ammonium shell. Polymerization of the assemblies yields soluble composite macromolecules. Light scattering data show that the macromolecule has an average size of about 310 nm in diameter in chloroform; AFM image illustrates that the macromolecule has an average diameter of 120 nm and an average height of 35 nm on a mica surface and photoluminescent spectra reveal that the macromolecule performs an extraordinary enhancement in fluorescence intensity of the semiconductor nanoparticles. These observations suggest that construction of macromolecules with supramolecular assembly as starting monomer may produce generations of materials with novel properties.


Asunto(s)
Compuestos de Cadmio/química , Cristalización/métodos , Transferencia Resonante de Energía de Fluorescencia/métodos , Colorantes Fluorescentes/síntesis química , Nanoestructuras/química , Nanoestructuras/ultraestructura , Compuestos de Selenio/química , Titanio/química , Compuestos Inorgánicos/química , Sustancias Macromoleculares/química , Ensayo de Materiales , Conformación Molecular , Nanotecnología/métodos , Compuestos Orgánicos/química , Tamaño de la Partícula , Propiedades de Superficie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA